第 1 到 28 筆結果,共 28 筆。

公開日期標題作者來源出版物scopusWOS全文
12023A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)Ang, Yvonne L E; Zhao, Xiaotian; Reungwetwattana, Thanyanan; Cho, Byoung-Chul; BIN-CHI LIAO ; Yeung, Rebecca; Loong, Herbert H; Kim, Dong-Wan; CHIH-HSIN YANG ; Lim, Sun Min; Ahn, Myung-Ju; Lee, Se-Hoon; Suwatanapongched, Thitiporn; Kongchauy, Kanchaporn; Ou, Qiuxiang; Yu, Ruoying; Tai, Bee Choo; Goh, Boon Cher; Mok, Tony S K; Soo, Ross ACancers10
22023Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinomaLim, Darren Wan-Teck; HSIANG-FONG KAO ; Suteja, Lisda; Li, Constance H; Quah, Hong Sheng; Tan, Daniel Shao-Weng; Tan, Sze-Huey; Tan, Eng-Huat; Tan, Wan-Ling; Lee, Justina Nadia; Wee, Felicia Yu-Ting; Jain, Amit; Goh, Boon-Cher; Chua, Melvin L K; BIN-CHI LIAO ; Ng, Quan Sing; RUEY-LONG HONG ; Ang, Mei-Kim; Yeong, Joe Poh-Sheng; Iyer, N GopalakrishnaNature communications51
32022Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysisHSIANG-FONG KAO ; HUAI-CHENG HUANG ; BIN-CHI LIAO ; RUEY-LONG HONG BMC cancer22
42022Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker AnalysisHSIANG-FONG KAO ; BIN-CHI LIAO ; YEN-LIN HUANG ; HUAI-CHENG HUANG ; Chun-Nan Chen ; TSENG-CHENG CHEN ; Hong, Yuan Jing; Chan, Ching Yi; JEAN-SAN CHIA ; RUEY-LONG HONG Clinical Cancer Research3328
52022肺癌用藥 你該知道的事臺大癌醫中心分院肺癌多專科診療團隊; JIN-SHING CHEN ; 莊仁豪; BIN-CHI LIAO ; 劉彥廷; YEN-TING LIN; ZONG-HAN YAO ; SHANG-GIN WU ; SHU-WEN LIN ; 何暐; 柯欣妏
62021Active or Attractive? Oral Antiangiogenesis Therapy Plus EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant NSCLCBIN-CHI LIAO ; CHIH-HSIN YANG Journal of Thoracic Oncology00
72021Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLCBIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG JTO clinical and research reports20
82021CD73 Is regulated by the EGFR-ERK signaling pathway in non-small cell lung cancerGriesing S.; BIN-CHI LIAO ; CHIH-HSIN YANG Anticancer Research1615
92021Lung Cancer in Republic of ChinaLuo Y.-H.; Chiu C.-H.; Scott Kuo C.-H.; Chou T.-Y.; Yeh Y.-C.; Hsu H.-S.; Yen S.-H.; Wu Y.-H.; CHIH-HSIN YANG ; BIN-CHI LIAO ; Hsia T.-C.; Chen Y.-M.Journal of Thoracic Oncology3326
102020Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving CrizotinibCHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU Oncologist1515
112020Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitorsCHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU European Journal of Cancer5549
122020Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung CancerHsu C.-C.; BIN-CHI LIAO ; WEI-YU LIAO ; Markovets A.; Stetson D.; Thress K.; CHIH-HSIN YANG Journal of Thoracic Oncology5644
132019Second-line treatment of EGFR T790M-negative non-small cell lung cancer patientsBIN-CHI LIAO ; Griesing S.; CHIH-HSIN YANG Therapeutic Advances in Medical Oncology2725
142018Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitorsBIN-CHI LIAO ; Bai Y.-Y; JIH-HSIANG LEE ; CHIA-CHI LIN ; SHU-YUNG LIN ; YEE-FAN LEE ; CHAO-CHI HO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG Journal of the Formosan Medical Association119
152018Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in TaiwanSHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU Journal of Cancer4041
162018Treating brain metastases in non-small cell lung cancer patients: what have we learnt from pharmaceutical recent clinical trials?BIN-CHI LIAO ; CHIA-CHI LIN ; CHIH-HSIN YANG Expert Opinion on Pharmacotherapy55
172017Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapyBIN-CHI LIAO ; Chia-Chi Lin ; JIH-HSIANG LEE ; CHIH-HSIN YANG Lung Cancer3835
182017Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosisJHE-CYUAN GUO ; CHIN-CHEN CHANG ; Yang C.-Y.; BIN-CHI LIAO ; JAU-YU LIAU ; Chang C.-H.; KUN-HUEI YEH Medical Oncology53
192017Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of AfatinibBIN-CHI LIAO ; CHIA-CHI LIN ; CHIH-HSIN YANG Current Oncology Reports1919
202016151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIsBIN-CHI LIAO ; Bai Y.-Y.; CHIA-CHI LIN ; SHU-YUNG LIN ; YEE-FAN LEE ; CHAO-CHI HO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG Journal of Thoracic Oncology11
212016Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily PracticeYI-HSIN LIANG ; YU-YUN SHAO ; BIN-CHI LIAO ; Lee, Ho-Sheng; CHIH-HSIN YANG ; Chen, Ho-Min; CHUN-JU CHIANG ; ANN-LII CHENG ; Lai, Mei-ShuJournal of Cancer87
222016Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitorsBIN-CHI LIAO ; CHIA-CHI LIN ; JIH-HSIANG LEE ; CHIH-HSIN YANG Journal of Biomedical Science4237
232015Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategyBIN-CHI LIAO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG Therapeutic Advances in Medical Oncology1616
242015Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinomaBIN-CHI LIAO ; YU-YUN SHAO ; Chen H.-M.; Shau W.-Y.; ZHONG-ZHE LIN ; Kuo R.N.; Lai C.-L.; KUO-HSING CHEN ; ANN-LII CHENG ; CHIH-HSIN YANG ; Lai M.-S.Clinical Lung Cancer118
252015Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal CarcinomatosisBIN-CHI LIAO ; JIH-HSIANG LEE ; CHIA-CHI LIN ; YA-FANG CHEN ; Chang C.-H.; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG Journal of Thoracic Oncology137113
262015Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancerBIN-CHI LIAO ; CHIA-CHI LIN ; CHIH-HSIN YANG Current Opinion in Oncology122109
272013First-line management of EGFR-mutated advanced lung adenocarcinoma: Recent developmentsBIN-CHI LIAO ; CHIA-CHI LIN ; CHIH-HSIN YANG Drugs1516
282012Front-line erlotinib in unselected patient with advanced NSCLC followed by standard chemotherapy with gemcitabine and cisplatin - TORCH studyBIN-CHI LIAO ; CHIH-HSIN YANG Translational Lung Cancer Research00